Receptor discordance in metastatic breast cancer describes the phenomena where the ER, PR or HER2 receptor status of the primary tumour subtype has changed when re-testing is performed by immunohistochemistry on the biopsy of corresponding metastatic tumour tissue. The gene discussed is PGR; the disease is neoplasm.